Clinical Trial Update: A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002 [Phase 1]

View source ↗

Summary

A Phase I trial of YS-HBV-002 for chronic hepatitis B has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• YS-HBV-002

Snippet

Sponsor: Yisheng Biopharma (Singapore) Pte. Ltd. | Conditions: Chronic Hepatitis B | Phase 1 | Status: TERMINATED